These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6052794)

  • 61. [Microzone electrophoresis of the nonconcentrated cerebrospinal fluid in nervous system diseases].
    Glasner H; Schmidt LR
    Nervenarzt; 1976 Nov; 47(11):675-81. PubMed ID: 63922
    [No Abstract]   [Full Text] [Related]  

  • 62. [Diagnostic value of cerebrospinal fluid analysis in myelopathies].
    Gårde A; Kjellin K
    Nord Med; 1971 May; 85(21):674-5. PubMed ID: 5581422
    [No Abstract]   [Full Text] [Related]  

  • 63. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions.
    Olsson JE; Link H
    Arch Neurol; 1973 Jun; 28(6):392-9. PubMed ID: 4121785
    [No Abstract]   [Full Text] [Related]  

  • 64. [The diagnostic significance of polyacrylamide electrophoresis in neuropsychiatry].
    Diessner H
    Psychiatr Neurol Med Psychol (Leipz); 1969 Oct; 21(10):384-6. PubMed ID: 4188698
    [No Abstract]   [Full Text] [Related]  

  • 65. [Monobrachial motorsensory form of multiple sclerosis].
    Dereux J; Dereux JF
    Rev Neurol (Paris); 1967 Jun; 116(6):705-7. PubMed ID: 4310107
    [No Abstract]   [Full Text] [Related]  

  • 66. [On the determination of total proteins in the cerebrospinal fluid].
    Meyer ; Werner E
    Z Laryngol Rhinol Otol; 1968 May; 47(5):391-2. PubMed ID: 5658853
    [No Abstract]   [Full Text] [Related]  

  • 67. Laboratory confirmation of multiple sclerosis on a drop of cerebrospinal fluid.
    Bray PF; Perry JJ; Hackett TN; Greene H; Jarcho LW
    Conn Med; 1974 Aug; 38(8):423-4. PubMed ID: 4414051
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical experience with polyacrylamide-electrophoretic analysis of cerebrospinal fluid proteins].
    Delank HW
    Klin Wochenschr; 1968 Jul; 46(14):779-83. PubMed ID: 5698724
    [No Abstract]   [Full Text] [Related]  

  • 69. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isoelectric focusing and immunofixation on cerebro-spinal fluid from multiple sclerosis patients.
    Cerrato D; Milanese C; Salmaggi A; La Mantia L; Ariano C; Corridori F; Nespolo A
    Acta Neurol (Napoli); 1985; 7(3-4):302-10. PubMed ID: 3904339
    [No Abstract]   [Full Text] [Related]  

  • 71. Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation.
    Ganrot K; Laurell CB
    Clin Chem; 1974 May; 20(5):571-3. PubMed ID: 4207912
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of Pantopaque myelography on cerebrospinal fluid fractions.
    Ferry DJ; Gooding R; Standefer JC; Wiese GM
    J Neurosurg; 1973 Feb; 38(2):167-71. PubMed ID: 4121016
    [No Abstract]   [Full Text] [Related]  

  • 73. [Is there a characteristic cerebrospinal fluid cell picture in multiple sclerosis? The significance of large pyronine-staining round cells in the cerebrospinal fluid].
    Schlote W; Roos W
    Nervenarzt; 1974 Nov; 45(11):576-87. PubMed ID: 4141753
    [No Abstract]   [Full Text] [Related]  

  • 74. [Lipids in the cerebrospinal fluid of patients with multiple sclerosis].
    Dupelj M; Trbojević-Cepe M; Arko K
    Acta Med Iugosl; 1982; 36(5):323-32. PubMed ID: 7158419
    [No Abstract]   [Full Text] [Related]  

  • 75. [Electrophoretic composition of cerebrospinal fluid proteins in selected chronic diseases of the central nervous system in children].
    Kaciński M; Adamczyk A; Wyszkowski J; Sokołowski A
    Pediatr Pol; 1981; 56(11-12):1291-6. PubMed ID: 7339555
    [No Abstract]   [Full Text] [Related]  

  • 76. [Cerebrospinal fluid diagnosis in spinal diseases].
    Schmidt RM
    Wien Klin Wochenschr; 1969 Dec; 81(50):909-12. PubMed ID: 5380793
    [No Abstract]   [Full Text] [Related]  

  • 77. [Evaluation of ACTH and corticosteroid therapy in multiple sclerosis].
    Hamel-Puskarić N; Arko K; Dupelj M; Novak Z; Barac B; Czukor M
    Neuropsihijatrija; 1969; 17(1):51-70. PubMed ID: 4191305
    [No Abstract]   [Full Text] [Related]  

  • 78. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Cerebrospinal fluid in multiple sclerosis].
    Igisu H; Shibasaki H; Kuroiwa Y
    Rinsho Shinkeigaku; 1974 Mar; 14(3):300-5. PubMed ID: 4472696
    [No Abstract]   [Full Text] [Related]  

  • 80. The electrophoretic pattern of cerebrospinal fluid proteins in the cutis verticis gyrata and mental retardation syndrome.
    Iivanainen M; Kostiainen E
    Eur Neurol; 1974; 11(1):30-6. PubMed ID: 4827506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.